Rosiglitazone-metformin combination clinical trials
How each study uses rosiglitazone-metformin combination is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 10 Oct 2002 · AVANDAMET · NDA 021410 (FDA, Drugs@FDA)
- European Union
- 20 Oct 2003 · Avandamet · EMEA/H/C/000522 (EMA; now expired)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Avandamet
- 4
Studies by the year they started
5 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 3
GlaxoSmithKline (2) · Canadian Heart Research Centre (1) · Samuel Lunenfeld Research Institute, Mount Sinai Hospital (1) · Intermountain Health Care, Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses rosiglitazone-metformin combination is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminCompletedPhase 4GlaxoSmithKlineNCT00386100Written as Avandamet 6 mg/1500 mg (ttd)
- Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)CompletedPhase 3Canadian Heart Research CentreNCT00131664Written as Avandamet
- A Lifestyle and Combination Medication Therapy Diabetes Prevention StudyCompletedPhase 3Samuel Lunenfeld Research Institute, Mount Sinai HospitalNCT00116922Written as Avandamet [Rosiglitazone 2mg/Metformin 500mg] BID
- Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot StudyTerminatedPhase 4Intermountain Health Care, Inc.NCT00343395Written as AVANDAMET
- AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 DiabetesCompletedPhase 3GlaxoSmithKlineNCT00359112Written as Avandamet